Henry O Gosebruch - Net Worth and Insider Trading
Henry O Gosebruch Net Worth
The estimated net worth of Henry O Gosebruch is at least $23 Million dollars as of 2024-11-13. Henry O Gosebruch is the EVP, Chief Strategy Officer of AbbVie Inc and owns about 98,580 shares of AbbVie Inc (ABBV) stock worth over $17 Million. Henry O Gosebruch is the President & CEO of Neumora Therapeutics Inc and owns about 524,793 shares of Neumora Therapeutics Inc (NMRA) stock worth over $6 Million. Henry O Gosebruch is also the Director of Acelyrin Inc and owns about 50,000 shares of Acelyrin Inc (SLRN) stock worth over $294,000. Besides these, Henry O Gosebruch also holds Aptinyx Inc (APTX) . Details can be seen in Henry O Gosebruch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Henry O Gosebruch has not made any transactions after 2023-09-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Henry O Gosebruch
Henry O Gosebruch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Henry O Gosebruch owns 4 companies in total, including Aptinyx Inc (APTX) , AbbVie Inc (ABBV) , and Acelyrin Inc (SLRN) among others .
Click here to see the complete history of Henry O Gosebruch’s form 4 insider trades.
Insider Ownership Summary of Henry O Gosebruch
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
APTX | Aptinyx Inc | 2020-01-10 | director |
ABBV | AbbVie Inc | 2022-05-16 | Chief Strategy Officer |
SLRN | Acelyrin Inc | 2023-05-09 | director |
2023-09-19 | director & President & CEO |
Henry O Gosebruch Latest Holdings Summary
Henry O Gosebruch currently owns a total of 4 stocks. Among these stocks, Henry O Gosebruch owns 98,580 shares of AbbVie Inc (ABBV) as of May 16, 2022, with a value of $17 Million and a weighting of 72.99%. Henry O Gosebruch owns 524,793 shares of Neumora Therapeutics Inc (NMRA) as of September 19, 2023, with a value of $6 Million and a weighting of 25.69%. Henry O Gosebruch also owns 50,000 shares of Acelyrin Inc (SLRN) as of May 9, 2023, with a value of $294,000 and a weighting of 1.27%. The other 1 stocks Aptinyx Inc (APTX) have a combined weighting of 0.05% among all his current holdings.
Latest Holdings of Henry O Gosebruch
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ABBV | AbbVie Inc | 2022-05-16 | 98,580 | 171.09 | 16,866,052 |
NMRA | Neumora Therapeutics Inc | 2023-09-19 | 524,793 | 11.31 | 5,935,409 |
SLRN | Acelyrin Inc | 2023-05-09 | 50,000 | 5.88 | 294,000 |
APTX | Aptinyx Inc | 2020-01-10 | 125,000 | 0.10 | 12,000 |
Holding Weightings of Henry O Gosebruch
Henry O Gosebruch Form 4 Trading Tracker
According to the SEC Form 4 filings, Henry O Gosebruch has made a total of 5 transactions in AbbVie Inc (ABBV) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in AbbVie Inc is the sale of 83,960 shares on May 16, 2022, which brought Henry O Gosebruch around $13 Million.
According to the SEC Form 4 filings, Henry O Gosebruch has made a total of 1 transactions in Neumora Therapeutics Inc (NMRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Neumora Therapeutics Inc is the acquisition of 15,000 shares on September 19, 2023, which cost Henry O Gosebruch around $189,300.
According to the SEC Form 4 filings, Henry O Gosebruch has made a total of 1 transactions in Acelyrin Inc (SLRN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Acelyrin Inc is the acquisition of 50,000 shares on May 9, 2023, which cost Henry O Gosebruch around $900,000.
More details on Henry O Gosebruch's insider transactions can be found in the Insider Trading History of Henry O Gosebruch table.Insider Trading History of Henry O Gosebruch
- 1
Henry O Gosebruch Trading Performance
GuruFocus tracks the stock performance after each of Henry O Gosebruch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Henry O Gosebruch is 1.48%. GuruFocus also compares Henry O Gosebruch's trading performance to market benchmark return within the same time period. The performance of stocks bought by Henry O Gosebruch within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Henry O Gosebruch's insider trading performs compared to the benchmark.
Performance of Henry O Gosebruch
Henry O Gosebruch Ownership Network
Ownership Network List of Henry O Gosebruch
Ownership Network Relation of Henry O Gosebruch
Henry O Gosebruch Owned Company Details
What does Aptinyx Inc do?
Who are the key executives at Aptinyx Inc?
Henry O Gosebruch is the director of Aptinyx Inc. Other key executives at Aptinyx Inc include director & CEO and President Norbert G Riedel , CFO and CBO Ashish Khanna , and 10 percent owner Bain Capital Life Sciences Investors, Llc .
Aptinyx Inc (APTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aptinyx Inc (APTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptinyx Inc (APTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aptinyx Inc (APTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aptinyx Inc Insider Transactions
Henry O Gosebruch Mailing Address
Above is the net worth, insider trading, and ownership report for Henry O Gosebruch. You might contact Henry O Gosebruch via mailing address: 1 N. Waukegan Road, North Chicago Il 60064-6092.